Whole-Genome Sequences of Two Multidrug-Resistant Acinetobacter baumannii Strains Isolated from Patients with Urinary Tract Infection in Ghana

Microbiology Resource Announcements
Nicholas AgyepongSabiha Essack

Abstract

Multidrug-resistant Acinetobacter baumannii is a major nosocomial pathogen. We describe the whole-genome sequences of two multidrug-resistant Acinetobacter baumannii strains isolated from hospitalized patients in the intensive care unit at Komfo Anokye Teaching Hospital in Ghana. The isolates carry multiple resistance genes, including those for β-lactams, sulfonamides, aminoglycosides, and tetracycline.

References

Apr 18, 2012·Journal of Computational Biology : a Journal of Computational Molecular Cell Biology·Anton BankevichPavel A Pevzner
Jul 12, 2012·The Journal of Antimicrobial Chemotherapy·Ea ZankariMette Voldby Larsen
Feb 21, 2013·Bioinformatics·Alexey GurevichGlenn Tesler
Apr 4, 2014·Bioinformatics·Anthony M BolgerBjoern Usadel
Oct 7, 2015·Intensive Care Medicine·José Garnacho-MonteroUNKNOWN European Society of Intensive Care Medicine
Nov 26, 2015·Infection and Drug Resistance·Japheth A OpintanWilliam Mills-Pappoe
Jun 28, 2016·Nucleic Acids Research·Tatiana TatusovaJames Ostell
Nov 2, 2017·The Journal of Antibiotics·Victoria L SimpkinElias Mossialos
Mar 16, 2018·Antimicrobial Resistance and Infection Control·Nicholas AgyepongSabiha Yusuf Essack

❮ Previous
Next ❯

Datasets Mentioned

BETA
PRJNA411997
NXHM00000000
SRX5417000
SRX5417001

Software Mentioned

Prokaryotic Genome Annotation Pipeline ( PGAP )
ResFinder
Trimmomatic
SPAdes
QUAST
PubMLST

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.